The combination product is non-formulary; substitute to the individual components (dorzolamide 2% and timolol 0.5% solution).
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines (Note: “Therapeutic Interchange” should be placed in the order comments
The combination product is non-formulary; substitute to the individual components (dorzolamide 2% and timolol 0.5% solution).
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments
Ophthalmic Glaucoma Agents
Medication
Class
Medication Ordered
Brand Name
Ordered Dosage
Frequency
Formulary
Medication
Equivalent Dose
Frequency
Prostaglandin Analogs
Bimatoprost
Lumigan
1 Drop to
Affected Eye
HS
Xalatan
(Latanoprost)
1 Drop to
Affected Eye
HS
Travoprost
Travatan
Travatan Z
Carbonic Anhydrase Inhibitor
Brinzolamide
Azopt
1 Drop to
Affected Eye
TID
Trusopt
(Dorzolamide)
1 Drop to
Affected Eye
TID
α2-agonist/beta-agonist
Brimonidine 0.2%/Timolol 0.5%
Combigan
1 Drop to Affected Eye
BID
Brimonidine 0.2%
1 Drop to Affected Eye
BID
Timolol 0.5%
1 Drop to Affected Eye
BID
α2-agonist
Brimonidine 0.1%, 0.15%
Alphagan, Alphagan P
Same Dose
Same Frequency
Brimonidine 0.2%
Same Dose
Same Frequency
Carbonic Anhydrase Inhibitor/beta-agonist
Dorzolamide/Timolol
Cosopt
1 Drop to
Affected Eye
BID
Dorzolamide 2%
1 Drop to Affected Eye
BID
Timolol 0.5%
1 Drop to Affected Eye
dorzolamide-timolol ophthalmic